Beyond Meat Valuation
Is BYND undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of BYND when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate BYND's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate BYND's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for BYND?
Key metric: As BYND is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is BYND's PS Ratio? | |
|---|---|
| PS Ratio | 1x |
| Sales | US$323.47m |
| Market Cap | US$318.84m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 4.4x |
| Enterprise Value/EBITDA | -10.5x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does BYND's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 0.5x | ||
SDSY.A South Dakota Soybean Processors | 0.5x | n/a | US$278.3m |
CVGW Calavo Growers | 0.5x | -13.1% | US$483.7m |
BGS B&G Foods | 0.3x | -0.05% | US$517.7m |
AFRI Forafric Global | 0.9x | n/a | US$278.2m |
BYND Beyond Meat | 1x | 3.7% | US$318.8m |
Price-To-Sales vs Peers: BYND is expensive based on its Price-To-Sales Ratio (1x) compared to the peer average (0.5x).
Price to Sales Ratio vs Industry
How does BYND's PS Ratio compare vs other companies in the US Food Industry?
Price-To-Sales vs Industry: BYND is expensive based on its Price-To-Sales Ratio (1x) compared to the US Food industry average (0.9x).
Price to Sales Ratio vs Fair Ratio
What is BYND's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 1x |
| Fair PS Ratio | 0.3x |
Price-To-Sales vs Fair Ratio: BYND is expensive based on its Price-To-Sales Ratio (1x) compared to the estimated Fair Price-To-Sales Ratio (0.3x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | US$4.89 | US$5.25 +7.4% | 20.8% | US$7.00 | US$3.00 | n/a | 8 |
| Nov ’25 | US$6.09 | US$5.38 -11.7% | 20.7% | US$7.00 | US$3.00 | n/a | 8 |
| Oct ’25 | US$6.40 | US$5.17 -19.3% | 23.3% | US$7.00 | US$3.00 | n/a | 9 |
| Sep ’25 | US$6.08 | US$5.17 -15.0% | 23.3% | US$7.00 | US$3.00 | n/a | 9 |
| Aug ’25 | US$6.14 | US$5.83 -5.0% | 31.8% | US$9.00 | US$3.00 | n/a | 9 |
| Jul ’25 | US$6.75 | US$5.83 -13.6% | 31.8% | US$9.00 | US$3.00 | n/a | 9 |
| Jun ’25 | US$7.59 | US$5.83 -23.1% | 31.8% | US$9.00 | US$3.00 | n/a | 9 |
| May ’25 | US$6.79 | US$6.50 -4.3% | 34.6% | US$10.00 | US$3.00 | n/a | 10 |
| Apr ’25 | US$7.76 | US$7.00 -9.8% | 35.0% | US$10.00 | US$3.00 | n/a | 10 |
| Mar ’25 | US$9.77 | US$7.00 -28.4% | 35.0% | US$10.00 | US$3.00 | n/a | 10 |
| Feb ’25 | US$6.69 | US$5.75 -14.1% | 29.9% | US$9.00 | US$3.00 | n/a | 10 |
| Jan ’25 | US$8.90 | US$5.75 -35.4% | 29.9% | US$9.00 | US$3.00 | n/a | 10 |
| Dec ’24 | US$7.57 | US$5.75 -24.0% | 29.9% | US$9.00 | US$3.00 | n/a | 10 |
| Nov ’24 | US$5.91 | US$8.93 +51.0% | 41.4% | US$13.00 | US$3.00 | US$6.09 | 10 |
| Oct ’24 | US$9.62 | US$9.95 +3.4% | 34.1% | US$13.00 | US$3.00 | US$6.40 | 10 |
| Sep ’24 | US$12.04 | US$10.50 -12.8% | 29.1% | US$13.00 | US$4.50 | US$6.08 | 9 |
| Aug ’24 | US$16.94 | US$10.42 -38.5% | 31.2% | US$14.00 | US$5.00 | US$6.14 | 12 |
| Jul ’24 | US$12.98 | US$10.42 -19.7% | 31.2% | US$14.00 | US$5.00 | US$6.75 | 12 |
| Jun ’24 | US$10.17 | US$10.77 +5.9% | 31.2% | US$15.00 | US$5.00 | US$7.59 | 13 |
| May ’24 | US$13.34 | US$13.08 -1.9% | 38.7% | US$20.00 | US$5.00 | US$6.79 | 12 |
| Apr ’24 | US$16.23 | US$12.58 -22.5% | 40.1% | US$20.00 | US$5.00 | US$7.76 | 12 |
| Mar ’24 | US$16.94 | US$12.38 -26.9% | 39.5% | US$20.00 | US$5.00 | US$9.77 | 13 |
| Feb ’24 | US$16.97 | US$10.46 -38.4% | 30.8% | US$15.00 | US$5.00 | US$6.69 | 13 |
| Jan ’24 | US$12.31 | US$13.00 +5.6% | 57.7% | US$35.00 | US$5.00 | US$8.90 | 15 |
| Dec ’23 | US$14.32 | US$14.97 +4.5% | 70.7% | US$45.00 | US$5.00 | US$7.57 | 16 |
| Nov ’23 | US$15.32 | US$17.97 +17.3% | 57.4% | US$45.00 | US$5.00 | US$5.91 | 16 |
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
Arca Continental. de
Mex$291.3b
Produces, distributes, and sells soft drinks in Mexico, Peru, the United States, Argentina, and Ecuador.
EMBV.F
Mex$8.56
7D
4.5%
1Y
-14.4%
Nestlé
CHF 195.4b
Operates as a food and beverage company.
NSRG.F
CHF 85.19
7D
-2.4%
1Y
-25.2%
B&G Foods
US$505.1m
Manufactures, sells, and distributes a portfolio of shelf-stable and frozen foods, and household products in the United States, Canada, and Puerto Rico.
BGS
US$6.54
7D
5.3%
1Y
-30.4%